164 related articles for article (PubMed ID: 3125593)
1. Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.
Puccetti L; Marotta G; Remorini E; Lucchetti A; Zuccotti M; Petrini G; Baicchi U; Ciompi ML
Rheumatol Int; 1987; 7(6):249-54. PubMed ID: 3125593
[TBL] [Abstract][Full Text] [Related]
2. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
[TBL] [Abstract][Full Text] [Related]
3. Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
Persellin ST; Daniels TM; Rings LJ; Kazmier FJ; Bowie EJ; Hunder GG
Mayo Clin Proc; 1985 Jul; 60(7):457-62. PubMed ID: 3925247
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
5. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis.
Federici AB; Fox RI; Espinoza LR; Zimmerman TS
Arthritis Rheum; 1984 Sep; 27(9):1046-9. PubMed ID: 6332630
[TBL] [Abstract][Full Text] [Related]
6. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
8. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activity.
Brun JG; Madland TM; Gran JT; Myklebust G
Scand J Rheumatol; 2005; 34(2):125-8. PubMed ID: 16095008
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL
Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088
[TBL] [Abstract][Full Text] [Related]
13. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
Park JR; Jones JG; Hazleman BL
Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
[TBL] [Abstract][Full Text] [Related]
14. Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity.
Grau RG; Kassan SS; Franks JJ; Kaplan H; Walker SH; Tan EM
Ann Rheum Dis; 1984 Oct; 43(5):721-4. PubMed ID: 6497463
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis.
Uddhammar AC
Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S32-3. PubMed ID: 10948757
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
17. Behavior of prealbumin in the acute phase of polymyalgia rheumatica treated with 6-methylprednisolone.
Puccetti L; Lucchetti A; Barbieri P; Melchiorre D; Zuccotti M; Petrini G; Marotta G; Remorini E; Ciompi ML
Ric Clin Lab; 1989; 19(3):251-8. PubMed ID: 2595195
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
19. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis.
Dasgupta B; Panayi GS
Br J Rheumatol; 1990 Dec; 29(6):456-8. PubMed ID: 2124160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
